LIVSANE Junior Schnupfen Xylo 0.05 %, Nasenspray, Lösung

7680702750019 CH-70275 Nasenspray
LIVSANE Junior Schnupfen Xylo 0.05 %, Nasenspray, Lösung
LIVSANE Junior Schnupfen Xylo 0.05 %, Nasenspray, Lösung
LIVSANE Junior Schnupfen Xylo 0.05 %, Nasenspray, Lösung
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
ml
Galenic form
Nasenspray
Galenic group
Nasenmittel

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/06/2026
Patient information leaflet
Français
24/06/2026
Patient information leaflet
Italien
24/06/2026
Summary of Product Characteristics
Allemand
24/06/2026
Summary of Product Characteristics
Français
24/06/2026

Detailed composition

Substance Quantity Type Category
xylometazolini hydrochloridum
0.5 MGML Substance Wirkstoff (Principe actif)
xylometazolini hydrochloridum
45.0 UG Substance WIZUS
kalii dihydrogenophosphas
- Substance HNIDK
aqua maris
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Pharmapost AG

4704 Niederbipp

Authorization information

Swissmedic authorization number
70275
Drug name
LIVSANE Schnupfen Xylo, Nasenspray, Lösung
Galenic form
NASSL
ATC Code
R01AA07
Authorization status
Z
Authorization category
Category C
Dispensing category
D
First authorization
05/06/2025
Authorization expiration date
31/12/9999
IT Number
12.02.1.
Domain
Human medicine
Field of application
Nasenschleimhautentzündung

Package details

Description (FR)
LIVSANE JUNIOR Rhume Xylo 0,05 % nasal spray
Description (DE)
LIVSANE JUNIOR Schnupfen Xylo 0,05 % Nasenspray
Market launch
01/12/2025
Narcotic (BTM)
No

Other package sizes (1)

LIVSANE Rhume Xylo 0.1 % nasal spray 1 mg/ml
10 ML
GTIN: 7680702750026
View
Buy us a coffee Explore the data